Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies

Laboratory Investigation

Volumn 78, Issue 6, 1998, Pages 715-726

  Chang, Yao ^a   Sheen, Tzung Shiahn ^a   Lu, Jean ^a   Huang, Yu Tzu ^a   Chen, Jen Yang ^a   Yang, Czau Siung ^a   Tsai, Ching Hwa ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; TUMOR BIOPSY; VIRUS CARCINOGENESIS; VIRUS TRANSCRIPTION;

ADULT; AGED; ANTIGENS, NUCLEAR; BIOPSY; CARCINOMA; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS;

EID: 0031748908     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, and Barrell BG (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
2. Brooks L, Yao QY, Rickinson AB, and Young LS (1992). Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: Coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 66:2689-2697.
3. Brooks LA, Lear AL, Young LS, and Rickinson AB (1993). Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 67:3182-3190.
4. Chen F, Hu LF, Ernberg I, Klein G, and Winberg G. (1995a). Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP2B genes in nasopharyngeal carcinomas. J Gen Virol 76:131-138.
5. Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, and Ernberg I. (1995b). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA2 or LMP1. J Virol 69:3752-3758.
6. Cooper NR, Moore MD, and Nemerow GR (1988). Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. Annu Rev Immunol 6:85-113.
7. Glaser R, Zhang HY, Yao K, Zhu HC, Wang FX, Li GY, Wen DS, and Li YP (1989). Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 86:9524-9528.
8. Graham FL and van der Eb AJ (1973). A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
9. Hermanek P and Sobin LH, editors (1987). TNM classification of malignant tumours. New York: Springer-Verlag.
10. Kieff E (1996). Epstein-Barr virus and its replication. In: Field BN, Knipe DM, and Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven, 2343-2396.
11. Kerr BM, Lear AL, Rowe M, Croom-Carter D, Young LS, Rookes SM, Gallimore PH, and Rickinson AB (1992). Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology 187:189-201.
12. Khanna R, Burrows SR, and Moss DJ (1995). Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 59:387-405.
13. Knox PG, Li QX, Rickinson AB, and Young LS (1996). In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus: Cell interaction observed in nasopharyngeal carcinoma. Virology 215:40-50.
14. Li QX, Young LS, Niedobitek G, Dawson CW, Birkenbach M, Wang F, and Rickinson AB (1992). Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 356:347-350.
15. Miller G and Lipman M (1973). Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190-194.
16. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, and Rickinson AB (1992). Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 140:879-887.
17. Pulvertaft RJV (1965). A study of malignant tumours in Nigeria by short-term tissue culture. J Clin Pathol 18:261-273.
18. Raab-Traub N, Hood R, Yang CS, Henry B II, and Pagano JS (1983). Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 48:580-590.
19. Rabson M, Gradoville L, Heston L, and Miller G (1982). Non-immortalizing P3J-HR-1 Epstein-Barr virus: A deletion mutant of its transforming parent, Jijoye. J Virol 44:834-844.
20. Reedman BM and Klein G (1973). Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 11:499-520.
21. Rickinson AB and Kieff E (1996). Epstein-Barr virus. In: Field BN, Knipe DM, and Howley PM, editors. Fields virology. Philadelphia: Lippincott-Raven, 2397-2446.
22. Rosa MD, Gottlieb E, Lerner MR, and Steitz JA (1981). Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1:785-796.
23. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasad U, and Rickinson AB (1993). Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J Cancer 53:957-962.
24. Schaefer BC, Strominger JL, and Speck SH (1995). Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci USA 92: 10565-10569.
25. Seigneurin JM, Lavoue MF, Genoulaz O, Bornkamm GW, and Lenoir GM (1987). Antibody response against the Epstein-Barr virus-coded nuclear antigen2 (EBNA2) in different groups of individuals. Int J Cancer 40:349-353.
26. Speck SH and Strominger JL (1989). Transcription of Epstein-Barr virus in latently infected, growth-transformed lymphocytes. Adv Viral Oncol 8:133-150.
27. Stoerker J, Yajima Y, and Glaser R (1982). The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines. Int J Cancer 30:385-392.
28. Takeuchi H, Kobayashi R, Hasegawa M, and Hirai K (1996). Detection of latent infection by Epstein-Barr virus in peripheral blood cells of healthy individuals and in non-neoplastic tonsillar tissue from patients by reverse transcription-polymerase chain reaction. J Virol Methods 58:81-89.
29. Tendler CL, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL, and Waldmann TA (1990). Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci USA 87:5218-5222.
30. Tierney RJ, Steven N, Young LS, and Rickinson AB (1994). Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374-7385.
31. Tsai CHA and Glaser R (1991). A comparison of Epstein-Barr virus specific proteins expressed by three Epstein-Barr virus isolates using specific monoclonal antibodies. Intervirology 32:376-382.
32. Tsai ST, Jin YT, and Su IJ (1996). Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization. Cancer 77:231-236.
33. Tugwood JD, Lau WH, Kio S, Tsao SY, Martin WMC, Shiu W, Desgranges C, Jones PH, and Arrand JR (1987). Epstein-Barr virus-specific transcription in normal and malignant nasopharyngeal biopsies and in lymphocytes from healthy donors and infectious mononucleosis patients. J Gen Virol 68:1081-1091.
34. Woisetschlaeger M, Jin XW, Yandava CN, Furmanski LA, Strominger JL, and Speck SH (1991). Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc Natl Acad Sci USA 88:3942-3946.
35. Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, and Ambinder RF (1991). Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. Am J Pathol 138:1461-1469.
36. Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, and Rickinson AB (1988). Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 69:1051-1065.
37. Zhang HY, Yao K, Zhu HC, and Glaser R (1990). Expression of the Epstein-Barr virus genome in a nasopharyngeal carcinoma epithelial tumor cell line. Int J Cancer 46:944-949.